Published in PLoS One on August 20, 2013
The role of microglia in diabetic retinopathy. J Ophthalmol (2014) 1.00
Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm (2015) 0.96
7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: a potential pathogenic mechanism underlying age-related macular degeneration. Sci Rep (2015) 0.89
Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease. Exp Eye Res (2014) 0.83
Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition. Diabetes (2014) 0.83
Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy. J Ophthalmol (2015) 0.83
Idiopathic preretinal glia in aging and age-related macular degeneration. Exp Eye Res (2015) 0.82
Neuroinflammation in glaucoma: A new opportunity. Exp Eye Res (2017) 0.78
Retinal phagocytes in age-related macular degeneration. Macrophage (Houst) (2015) 0.78
Aryl hydrocarbon receptor knock-out exacerbates choroidal neovascularization via multiple pathogenic pathways. J Pathol (2014) 0.78
Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat model. J Ocul Pharmacol Ther (2014) 0.77
Friend or Foe? Resident Microglia vs Bone Marrow-Derived Microglia and Their Roles in the Retinal Degeneration. Mol Neurobiol (2016) 0.76
The Immune System and AMD. Curr Ophthalmol Rep (2014) 0.76
An Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease Pathology. Mol Diagn Ther (2017) 0.76
Lymphocytic Microparticles Modulate Angiogenic Properties of Macrophages in Laser-induced Choroidal Neovascularization. Sci Rep (2016) 0.75
Age-related macular degeneration phenotypes are associated with increased tumor necrosis-alpha and subretinal immune cells in aged Cxcr5 knockout mice. PLoS One (2017) 0.75
A Quantitative and Standardized Method for the Evaluation of Choroidal Neovascularization Using MICRON III Fluorescein Angiograms in Rats. PLoS One (2015) 0.75
Macrophage polarization in experimental and clinical choroidal neovascularization. Sci Rep (2016) 0.75
Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization. Mol Med Rep (2017) 0.75
High-resolution contrast-enhanced optical coherence tomography in mice retinae. J Biomed Opt (2016) 0.75
A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization. J Cell Mol Med (2017) 0.75
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature (2008) 7.10
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med (2003) 6.61
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med (2002) 5.50
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood (1996) 5.31
CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest (2007) 3.39
Accuracy and precision in quantitative fluorescence microscopy. J Cell Biol (2009) 2.98
Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res (2003) 2.73
Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep (2006) 2.69
VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 2.38
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol (1998) 2.33
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell (2010) 2.26
The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci (2009) 1.84
Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS One (2009) 1.68
Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci (2006) 1.56
The role of adult bone marrow-derived stem cells in choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 1.52
Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. Exp Eye Res (2005) 1.50
Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol (1997) 1.44
Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy. Invest Ophthalmol Vis Sci (2008) 1.42
Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res (2000) 1.40
Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2004) 1.38
Embryonic and postnatal development of microglial cells in the mouse retina. J Comp Neurol (2008) 1.32
Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol (2006) 1.28
Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology (2007) 1.26
Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int (2005) 1.23
Interleukin-1β inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. Am J Pathol (2011) 1.22
Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes. Invest Ophthalmol Vis Sci (2008) 1.19
The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vis (1999) 1.18
Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci (2003) 1.14
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. Mediators Inflamm (2010) 1.11
Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol (2002) 1.10
A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS One (2011) 1.09
PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets. Proc Natl Acad Sci U S A (2010) 1.08
Microglial VEGF receptor response is an integral chemotactic component in Alzheimer's disease pathology. J Neurosci (2009) 1.07
A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap. Invest Ophthalmol Vis Sci (2010) 1.06
A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection. Am J Pathol (2010) 1.05
Review of the ocular angiogenesis animal models. Semin Ophthalmol (2009) 1.02
Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761. Invest Ophthalmol Vis Sci (2007) 0.99
Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization. Invest Ophthalmol Vis Sci (2009) 0.96
Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J Biol Chem (2011) 0.96
Argon laser photocoagulation-induced modification of gene expression in the retina. Invest Ophthalmol Vis Sci (2003) 0.95
Role of ocular complement factor H in a murine model of choroidal neovascularization. Am J Pathol (2010) 0.95
Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye. PLoS One (2011) 0.95
Differences in the temporal expression of regulatory growth factors during choroidal neovascular development. Exp Eye Res (2008) 0.94
Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Invest Ophthalmol Vis Sci (2009) 0.91
Molecular dynamics of photoreceptor synapse formation in the developing chick retina. J Comp Neurol (2008) 0.91
SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation. Microvasc Res (2007) 0.87
Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation. J Biol Chem (2010) 0.87
Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration. Invest Ophthalmol Vis Sci (2011) 0.86
Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization. J Biol Chem (2011) 0.85
Factors determining age-related macular degeneration: a current view. Medicina (Kaunas) (2010) 0.83
Recruitment of blood-derived inflammatory cells mediated via tumor necrosis factor-α receptor 1b exacerbates choroidal neovascularization. Invest Ophthalmol Vis Sci (2011) 0.82
Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 2.40
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease. Blood (2005) 2.37
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell (2010) 2.26
Developmental basis of nanophthalmos: MFRP Is required for both prenatal ocular growth and postnatal emmetropization. Ophthalmic Genet (2008) 2.15
Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res (2005) 1.84
Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci (2002) 1.71
Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol (2002) 1.57
Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci (2004) 1.56
TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci (2011) 1.47
Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal (2012) 1.40
Astrocyte-endothelial cell relationships during human retinal vascular development. Invest Ophthalmol Vis Sci (2004) 1.27
The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas. Exp Eye Res (2005) 1.21
Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest Ophthalmol Vis Sci (2002) 1.20
betaA3/A1-crystallin in astroglial cells regulates retinal vascular remodeling during development. Mol Cell Neurosci (2007) 1.18
Activation of microglia and chemokines in light-induced retinal degeneration. Mol Vis (2005) 1.16
Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2002) 1.15
C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br J Ophthalmol (2011) 1.09
Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier. J Cell Physiol (2003) 1.08
Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid. Exp Eye Res (2003) 1.06
Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels. J Cell Physiol (2008) 1.06
Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes (2005) 1.06
Vascular precursors in developing human retina. Invest Ophthalmol Vis Sci (2008) 1.05
A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection. Am J Pathol (2010) 1.05
High glucose-induced altered basement membrane composition and structure increases trans-endothelial permeability: implications for diabetic retinopathy. Curr Eye Res (2011) 1.05
The embryonic human choriocapillaris develops by hemo-vasculogenesis. Dev Dyn (2007) 1.04
Low nitric oxide synthases (NOSs) in eyes with age-related macular degeneration (AMD). Exp Eye Res (2009) 1.03
Retinal and optic nerve head pathology in Susac's syndrome. Ophthalmology (2011) 1.02
Lama1 mutations lead to vitreoretinal blood vessel formation, persistence of fetal vasculature, and epiretinal membrane formation in mice. BMC Dev Biol (2011) 1.02
Mutation in the βA3/A1-crystallin gene impairs phagosome degradation in the retinal pigmented epithelium of the rat. J Cell Sci (2011) 1.01
Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGF-induced vascular permeability. PLoS One (2011) 1.00
Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration. Arch Ophthalmol (2008) 0.99
Maturation of the fetal human choriocapillaris. Invest Ophthalmol Vis Sci (2009) 0.98
Role of Nrf2 in retinal vascular development and the vaso-obliterative phase of oxygen-induced retinopathy. Exp Eye Res (2010) 0.97
Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization. Invest Ophthalmol Vis Sci (2009) 0.96
Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye. PLoS One (2011) 0.95
Hyperoxia inhibits several critical aspects of vascular development. Dev Dyn (2007) 0.93
Retinopathy in monkeys with spontaneous type 2 diabetes. Invest Ophthalmol Vis Sci (2004) 0.92
VEGF 165 b in the developing vasculatures of the fetal human eye. Dev Dyn (2012) 0.91
Transgenic expression of leukemia inhibitory factor (LIF) blocks normal vascular development but not pathological neovascularization in the eye. Mol Vis (2005) 0.90
The deletion of Math5 disrupts retinal blood vessel and glial development in mice. Exp Eye Res (2011) 0.89
Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation. Mol Vis (2011) 0.89
The proteome of human retina. Proteomics (2015) 0.89
Increased Lipocalin-2 in the retinal pigment epithelium of Cryba1 cKO mice is associated with a chronic inflammatory response. Aging Cell (2014) 0.88
The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy. Proteomics Clin Appl (2014) 0.88
Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Nanomedicine (2008) 0.87
Nanoparticle tethered antioxidant response element as a biosensor for oxygen induced toxicity in retinal endothelial cells. Mol Vis (2006) 0.87
βA3/A1-crystallin is required for proper astrocyte template formation and vascular remodeling in the retina. Transgenic Res (2012) 0.87
Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration. Invest Ophthalmol Vis Sci (2011) 0.86
Mouse model of post-surgical breakdown of the blood-retinal barrier. Curr Eye Res (2004) 0.84
From blood islands to blood vessels: morphologic observations and expression of key molecules during hyaloid vascular system development. Invest Ophthalmol Vis Sci (2012) 0.82
Laser targeted photo-occlusion of rat choroidal neovascularization without collateral damage. Photochem Photobiol (2002) 0.80
Co-expression of endothelial and neuronal nitric oxide synthases in the developing vasculatures of the human fetal eye. Graefes Arch Clin Exp Ophthalmol (2012) 0.79
[Construction of the stable expression system of NIH3T3 fibroblast with pcDNA3.1(-)-hTGFbeta3 and the study on the proliferation of the system fibroblasts]. Zhonghua Zheng Xing Wai Ke Za Zhi (2006) 0.78
Preliminary ocular histopathological observations on heterozygous NEMO-deficient mice. Exp Eye Res (2008) 0.78
Parstatin suppresses ocular neovascularization and inflammation. Invest Ophthalmol Vis Sci (2010) 0.78
Nanoparticle-delivered biosensor for reactive oxygen species in diabetes. Vision Res (2008) 0.76
Effects of sickle cell disease on the eye: clinical features and treatment. Hematol Oncol Clin North Am (2005) 0.76
Albumen Transport to Bruch's Membrane and RPE by Choriocapillaris Caveolae. Invest Ophthalmol Vis Sci (2016) 0.75
Adult Human Choroid: An Alymphatic Tissue? Invest Ophthalmol Vis Sci (2015) 0.75
Nanoscale biosensor for detection of reactive oxygen species. Methods Mol Biol (2013) 0.75
Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition. diabetes 2015;64:200-212. Diabetes (2015) 0.75